[Gastroesophageal reflux disease: pathogenesis, clinical manifestation, diagnostics, and treatment].
Tsimmerman
Ia S
IaS
Vologzhanina
L G
LG
D000536:Aluminum Hydroxide / Q000627:therapeutic use; D000863:Antacids / Q000627:therapeutic use; D000897:Anti-Ulcer Agents / Q000627:therapeutic use; D000934:Antifoaming Agents / Q000627:therapeutic use; D004338:Drug Combinations; D005764:Gastroesophageal Reflux / Q000175:diagnosis / Q000188:drug therapy / Q000503:physiopathology; D005773:Gastroscopy / Q000379:methods*; D006801:Humans; D008276:Magnesium Hydroxide / Q000627:therapeutic use; D011899:Ranitidine / Q000627:therapeutic use; D012841:Simethicone / Q000627:therapeutic use
D000863:Antacids; D000897:Anti-Ulcer Agents; D000934:Antifoaming Agents; D004338:Drug Combinations; C013591:aluminum hydroxide, magnesium hydroxide, drug combination; D000536:Aluminum Hydroxide; D012841:Simethicone; D011899:Ranitidine; D008276:Magnesium Hydroxide